PCSK9 and hypertriglyceridemia: Thus, high level of serum PCSK9, promoting VLDL-R and CD36 degradation, could also contribute to elevated serum VLDL–cholesterol and FFA level (Fig. 1b) leading to hypertriglyceridemia found in lipectomized rats [17, 18].